Hastane Kaynaklı Enfeksiyonlarda Güncel Durum

Nozokomiyal enfeksiyonlar yoğun bakım ünitelerindeki en önemli problemlerdendir. Bu enfeksiyonların kritik has- talarda mortalite ve morbiditeyi arttırdığı ve hastanede kalış süresini uzatıp maliyeti arttırdığı iyi bilinmektedir. No- zokomiyal enfeksiyonların çoğu invaziv medikal ya da cerrahi girişimlerle ilişkilidir. Ventilatör ilişkili pnömoni,idrar yolu enfeksiyonu, primer ya da kateter ilişkili kan dolaşımı enfeksiyonları hala yoğun bakım ünitelerinde sıkolarak görülmektedir. Enfeksiyon kontrol programlarının uygulanması, nozokomiyal enfeksiyonların tanısı ve yö- netimi rehberlerinin kullanılması, hastane enfeksiyonlarının azalmasında ve antibiyotiklerin gereksiz kullanımınınazaltılmasında en önemli kriterlerdir.

Current State of Nasocomial Infection

Nasocomial infections are becoming one of the most important problems in intensive care units. It is well knownthat these infections are major cause of morbidity and mortality in critically ill patients and are associated with inc- reases in the lenght of stay and excessive hospital costs. Most nasocomial infections are associated with using inva- sive medical or surgical procedure. Ventilator associated pneumoniae, urinary tract infections and both primary andcatheter related bloodstream infections incidance are high in intensive care units. Using infection control programs,diagnostic criteria and management guidelines for nasocomial infections are essential to help reduce the incidanceof nasocomial infections and unnecessary usage of antibiotics.

PDF

___

1. Zaragoza R, Ramirez P, Lopez-duego MJ. Nasocomial infectıons in intensive care units. Enferm ınfec Mıcrobiol Clin. 2014 May; 32 (5):320-7. 2. Peleg AY,Hooper DC Hospital-acquıred infections due to gram- negative bacteria. N Engl J Med. 2010 May 13;362(19):1804-13. 3. Tükenmez Tigen E, Doğru A, Koltka EN, Ünlü C. Device-associ- ated nasocomial infection rates and distribution of antimicrobial resistance in a medical-surgical intensive care unit in Turkey. Jpn J Infect Dis. 2014; 67(1):5-8. 4. Rosenthal VD, Maki DG, Leblebicioğlu H, Memish ZA. Internati- onal nasocomial infection control consortium (INICC) report, data summary of 43 countries for 2007-2012.Device associated modü- le. Am J Infect Control. 2014 Sep;42(9):942-56. 5. Gür D. Antibiyotik direnç mekanizmaları; in Köksal İ, Çakar N, Arman D. (eds) Yoğun bakım enfeksiyonları Bilimsel Tıp Yayıne- vi Ankara 2005:959-72) 6. Khorvash F, Abbasi S, Yaran M, Ataei B. Molecular detection of Candida spp. And Aspergillus fumigatus in bronchoalveolar lava- ge fluid patients with ventilator-associated pneumonia. J.Res. Med Sci. 2014 Mar 19 (suppl 1):S46-50. 7. Xia YL, Ge M, Wang Z.Pathogenic analysis of ventilator-associa- ted pneumoniae in the pediatric intensive care unit in high altitude areas. Article in chinese. Zhongguo Dang Dai Er Ke Za Zhi . 2014 Aug;16(8):787-90. 8. Bassi GL, Ferrer M, Marti JD, Comaru T. Ventilator-associated pneumoniae. Semin respir. Crit. Care Med. 2014 aug; 35(4):469- 81. 9. Charles MW, Easow JM, Joseph NM, Ravishankar M. Role of Appropriate Therapy in Combating Mortality Among The Venti- late Patients. J Clin Diagn Res 2014 Aug;8(8):1-3.) 10. Niederman MS, Chastre J, Solem CT, Wan YHealth economic eva- luation of patients treated for nasocomial pneumoniae caused by methicillin resistant Staphylococcus aureus:Secondary analysis of a multicenter randomized clinical trial of vancomycin and linezo- lid. Clin Ther 2014 sep 1;36(9):1233-1243. 11. Zeng Q, Xu F, Jiang S. Diagn Microbial Infect Dis. 2014 Oct; 80(2):136-40. 12. Leistner R, Gürntke S, Sakellariou C, Denkel CA. Bloodstream in- fection due to extended-spectrum beta-lactamase (ESBL)-positive K. Pneumoniae and E. coli: An analysis of the disease burden in a large cohort. Infection 201 aug 7. 13. Levesque S, Bourgault AM, Galarneau LA, Moison P. Molecu- lar epidomiology and antimicrobial susceptibility of methicilline resistant Staphylococcus aureus blood culture ısolates. Epidomiol Infect. 2014 Aug. 20:1-8. 14. Gürntkev S, Kohler C, Steinmetz I, Pfeifer Y. Molecular epidemio- logy of extended-spectrum beta-lactamase (ESBL) positive Kleb- siella pneumoniae from bloodstream infections and risk factors for mortality. J. Infect Chemother. 2014 sep 12: 1341-21. 15. Climo MW, Yokoe DS, Warren DK, Perl TM. Effect of daily chlor- hexidine bathing on hospital acquired infection.New England Jo- urnal of Medicine. 2013 Feb 7; 368 (6):533-42. 16. Soltani R, Ehsanpoor M, Khorvash F, Shokri D. Antimicrobial Sus- ceptibility pattern of extended-spectrum beta-lactamase-producing bacteria causing nasocomial urinary tract infections in an Irranian referral teaching hospital. j Res Pharm pract. 2014 Jan;3(1):6-11. 17. Moayednia Y, Shokri D, Mobasherizadeh S, Baradaran A. Frequ- ency assesment of Beta lactamase enzymes in Esherichia coli and Klebsiella isolates in patients with urinary tract infection. J. Res Med Sci. 2014 Mar;19 (suppl 1):S41-5. 18. Koningstein M, Van Der Bij Ak, De Kraker ME, Monen JC. Re- commendations for the empirical treatment of complicated uri- nary tract infections using surveillance data on antimicrobial resis- tance in the Netherlands.PLoS one 2014 Jan28;9(1).